Transdermal Drug Delivery Systems Market Size and Insights 2031
Precision Business Insights has published a
report on the global transdermal drug delivery systems market, estimating its
value at USD 74.1 billion in 2024 and is expected to expand at a compound
annual growth rate (CAGR) of 11.9% over the forecast period 2025-2031. The
report explores the market growth and potential opportunities in the market
industry. Additionally, it offers a detailed analysis of how these elements
will affect market demand dynamics and market performance throughout the
forecast period.
View
the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/transdermal-drug-delivery-systems-market
Market Definition:
Transdermal Drug
Delivery Systems (TDDS) are innovative drug delivery methods that allow
medications to be absorbed through the skin into the bloodstream. These systems
offer several advantages, such as avoiding first-pass metabolism, providing
controlled drug release, and enhancing patient convenience.
Drivers:
1)
Rising prevalence of chronic
diseases.
2)
Growing homecare adoption.
The global transdermal drug delivery
systems market segmentation:
1) By Application: Cardiovascular, Contraception, Pain Management /
Neurological Disorders, Smoking Cessation, Others.
2) By Technology: Electric Current, Electroporation, Radio Frequency, Thermal,
Ultrasound, Others.
Regional Overview:
The report also examines the current concerns and
their Future Effects on the transdermal drug delivery systems market by
the region. The report covers all regions and countries, North America was the
largest and Asia was the fastest-growing region in the transdermal drug
delivery systems market. The market has been segmented into numerous
primary regions and a detailed evaluation of primary countries.
·
North America (U.S., Canada)
·
Europe (Germany, U.K., France,
Italy, Russia, Spain, Rest of Europe)
·
Asia-Pacific (China, India,
Japan, Australia, Southeast Asia, Rest of Asia Pacific)
·
Latin America (Mexico, Brazil,
Argentina, Columbia, Rest of Latin America)
·
Middle East & Africa (GCC,
Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive
landscape is dominated by major players like Novartis AG (Switzerland),
Boehringer Ingelheim GmbH (Germany), Generex Biotechnology Corp. (Canada), Echo
Therapeutics, Inc. (U.S.), Crescita Therapeutics Inc (Canada), MedPharm (U.K.),
Pantec Biosolutions AG (Liechtenstein), Transdermal Corp. (U.S.), Noven
Pharmaceuticals, Inc. (U.S.), Actelion Pharmaceuticals Ltd (Switzerland),
Johnson & Johnson Limited (U.S.), 3M Pharmaceuticals Inc. (U.S.), Mylan
Pharmaceuticals Inc. (U.S.), GlaxoSmithKline plc (U.K.)
About Precision Business Insights:
We are a market research company that strives
to provide the highest quality market research insights. Our diverse market
research experts are enthusiastic about market research and therefore produce
high-quality research reports. We have over 500 clients with whom we have a
good business partnership and capacity to provide in-depth research analysis
for more than 30 countries. In addition to deliver more than 150 custom
solutions, we already have accounts with the top five medical device
manufacturers.
Precision Business Insights offers a variety of cost-effective and
customized research services to meet research requirements. We are a leading
research service provider because of our extensive database built by our
experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll
Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U
N S® Number: 852781747
Comments
Post a Comment